Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain
In recent years, health research has been undergoing two major, yet seemingly opposing, shifts: a deep dive into individual-centric medicine and a broadened focus on population-wide studies. On the individual level, advancements in genomics are driving the shift toward personalized medicine, where
Cervical cancer, despite being largely preventable, continues to claim the lives of two women in the UK every day—a stark reminder of the ongoing battle against the disease. In a bid to change this grim statistic, NHS England has committed to an ambitious goal of eliminating cervical cancer by
In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and acute
The ability to control matter at the atomic level with remarkable precision has long been a dream in the field of nanotechnology. Recent advancements led by physicists at the University of Bath, in collaboration with an international team, have brought us closer to this goal. This breakthrough
In a groundbreaking move aiming to reshape the process of diagnosing colorectal cancer, the Community Diagnostic Centre (CDC) in Telford has launched a £1 million research study known as TRIOMIC. This innovative study is designed to significantly shorten the anxiety-inducing waiting period for a
